A growing body of new clinical and health-economic evidence presented at Wounds UK 2025 has reinforced the value of subsensory electrical stimulation therapy (EST) delivered via Accel-Heal. Four real-world clinical evaluations and a major economic analysis collectively demonstrate the therapy’s potential to accelerate healing, reduce pain, and improve patient quality of life, while also supporting more efficient use of health-care resources.
The findings provide important new insights into how Accel-Heal can be integrated into contemporary wound-care pathways, particularly for patients with chronic or stalled wounds who have not responded to standard care.
New Evidence Presented at Wounds UK 2025
1. Rapid Healing of a Painful Venous Leg Ulcer Using Sub-Sensory Microcurrent Electrical Stimulation
Holland et al.
A real-world case reporting accelerated healing and rapid pain relief in a complex venous leg ulcer (VLU) following treatment with Accel-Heal.
Holland et al poster Wounds UK 2025 – Final
2. From Pain to Healing: A Case Series of Complex Wounds Treated with Sub-Sensory Electrical Stimulation Therapy (Accel-Heal Solo)
Russell et al.
A multi-case series demonstrating consistent improvements in healing trajectories and pain levels across diverse chronic wound types.
Russell et al poster Wounds UK 2025 – Final
3. Impact of a Single-Use 12-Day Electrical Stimulation Therapy Device on Wound Pain, Healing and Compression Tolerance in Lower-Limb Venous Ulcers
Patullo & Ovens
A real-world evaluation reporting reductions in wound pain, improved compression tolerance, and early indicators of accelerated healing in VLU patients.
Patullo and Ovens poster Wounds UK 2025 – Final
4. Faster, Painless and Healthier Wound Recovery: Pulsed-Current Electrical Stimulation for Venous Leg Ulcers
Fu & Jeffery
Evidence showing reduced pain and improved healing outcomes in VLU patients treated with pulsed-current EST.
Fu and Jeffery Wounds UK 2025
5. Cost-Effectiveness of Electrical Stimulation Therapy in Chronic Wounds within the NHS
Smith et al.
A comprehensive economic review indicating that EST has the potential to reduce overall treatment time, clinic visits and wound-care costs across the NHS.
Smith et al Wounds UK 2025
Advancing the Evidence Base for Accel-Heal
Across all five contributions, a consistent pattern emerges:
- Accelerated healing in complex, slow-to-resolve wounds
- Meaningful reductions in pain, improving tolerance to essential therapy such as compression
- Enhanced patient experience and quality of life
- Potential cost savings for health-care providers and payers